BRPI0913997A2 - isolamento de ciclopamina - Google Patents

isolamento de ciclopamina

Info

Publication number
BRPI0913997A2
BRPI0913997A2 BRPI0913997A BRPI0913997A BRPI0913997A2 BR PI0913997 A2 BRPI0913997 A2 BR PI0913997A2 BR PI0913997 A BRPI0913997 A BR PI0913997A BR PI0913997 A BRPI0913997 A BR PI0913997A BR PI0913997 A2 BRPI0913997 A2 BR PI0913997A2
Authority
BR
Brazil
Prior art keywords
cyclopamine
isolation
cyclopamine isolation
Prior art date
Application number
BRPI0913997A
Other languages
English (en)
Inventor
David A Mann
Gamini Senerath Jayatilake
Steven L Richheimer
Original Assignee
Infinity Discovery Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Infinity Discovery Inc filed Critical Infinity Discovery Inc
Publication of BRPI0913997A2 publication Critical patent/BRPI0913997A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J69/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by contraction of only one ring by one atom and expansion of only one ring by one atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40—Oxygen atoms
    • C07D211/42—Oxygen atoms attached in position 3 or 5
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C07D491/044—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
    • C07D491/048—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being five-membered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/24—Condensed ring systems having three or more rings
    • C07H15/256—Polyterpene radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J61/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by contraction of only one ring by one or two atoms
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/10—Nitrogen as only ring hetero atom
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/18—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
    • C12P17/188—Heterocyclic compound containing in the condensed system at least one hetero ring having nitrogen atoms and oxygen atoms as the only ring heteroatoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Hydrogenated Pyridines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Extraction Or Liquid Replacement (AREA)
BRPI0913997A 2008-07-02 2009-07-01 isolamento de ciclopamina BRPI0913997A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US7770308P 2008-07-02 2008-07-02
PCT/US2009/049372 WO2010002970A2 (en) 2008-07-02 2009-07-01 Isolation of cyclopamine

Publications (1)

Publication Number Publication Date
BRPI0913997A2 true BRPI0913997A2 (pt) 2015-10-20

Family

ID=41464684

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0913997A BRPI0913997A2 (pt) 2008-07-02 2009-07-01 isolamento de ciclopamina

Country Status (14)

Country Link
US (3) US20100003728A1 (pt)
EP (1) EP2318027B1 (pt)
JP (1) JP5607041B2 (pt)
KR (1) KR20110028640A (pt)
CN (1) CN102137679B (pt)
AR (1) AR074524A1 (pt)
AU (1) AU2009266993A1 (pt)
BR (1) BRPI0913997A2 (pt)
CA (1) CA2729110A1 (pt)
CL (1) CL2009001479A1 (pt)
IL (1) IL210149A (pt)
PE (1) PE20100258A1 (pt)
TW (1) TW201006484A (pt)
WO (1) WO2010002970A2 (pt)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI433674B (zh) 2006-12-28 2014-04-11 Infinity Discovery Inc 環杷明(cyclopamine)類似物類
EP2134719B1 (en) 2007-03-07 2013-07-17 Infinity Discovery, Inc. Cyclopamine lactam analogs and methods of use thereof
CN101687877B (zh) 2007-03-07 2014-07-23 无限发现股份有限公司 杂环环杷明类似物及其使用方法
US20100297118A1 (en) * 2007-12-27 2010-11-25 Macdougall John Therapeutic Cancer Treatments
JP2011522773A (ja) * 2007-12-27 2011-08-04 インフィニティ ファーマスーティカルズ、インク. 治療剤での癌の処置方法
WO2009086451A1 (en) * 2007-12-27 2009-07-09 Infinity Pharmaceuticals, Inc. Methods for stereoselective reduction
CA2636807A1 (en) * 2008-07-04 2010-01-04 Steven Splinter Methods for obtaining cyclopamine
CA2766050C (en) * 2009-06-18 2018-09-25 Phyton Holdings, Llc Production of alkaloids by liliaceae cell culture
CA2769795C (en) 2009-08-05 2020-01-07 Infinity Pharmaceuticals, Inc. Enzymatic transamination of cyclopamine analogs
WO2011057222A1 (en) * 2009-11-06 2011-05-12 Infinity Pharmaceuticals, Inc. Oral formulations of a hedgehog pathway inhibitor
WO2011088404A1 (en) * 2010-01-15 2011-07-21 Infinity Pharmaceuticals , Inc Treatment of fibrotic conditions using hedgehog inhibitors
US9376447B2 (en) 2010-09-14 2016-06-28 Infinity Pharmaceuticals, Inc. Transfer hydrogenation of cyclopamine analogs
CN104861034B (zh) * 2014-02-24 2017-04-19 中国人民解放军第二军医大学 环巴胺类似物三元环环巴胺及其衍生物与制备和应用
BR112017026103B1 (pt) 2015-06-04 2023-10-03 Sol-Gel Technologies Ltd Composições tópicas com composto inibidor de hedgehog, sistema de entrega tópica e seus usos

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6333341A (ja) * 1986-07-28 1988-02-13 Seitetsu Kagaku Co Ltd 配糖体の処理方法
US6993456B2 (en) * 1999-09-30 2006-01-31 Rockwell Automation Technologies, Inc. Mechanical-electrical template based method and apparatus
US6456928B1 (en) * 2000-12-29 2002-09-24 Honeywell International Inc. Prognostics monitor for systems that are subject to failure
AU2003244088A1 (en) * 2002-06-20 2004-01-06 Nippon Suisan Kaisha, Ltd. Produrg, medicinal utilization thereof and process for producing the same
US20090305338A1 (en) * 2006-09-29 2009-12-10 Anneli Ritala-Nurmi Plant cell lines established from the medicinal plant veratrum californicum
CA2636807A1 (en) * 2008-07-04 2010-01-04 Steven Splinter Methods for obtaining cyclopamine

Also Published As

Publication number Publication date
WO2010002970A3 (en) 2010-05-06
IL210149A (en) 2016-03-31
KR20110028640A (ko) 2011-03-21
JP2011526921A (ja) 2011-10-20
IL210149A0 (en) 2011-03-31
AR074524A1 (es) 2011-01-26
CA2729110A1 (en) 2010-01-07
WO2010002970A2 (en) 2010-01-07
CN102137679A (zh) 2011-07-27
EP2318027A2 (en) 2011-05-11
CN102137679B (zh) 2013-04-24
AU2009266993A1 (en) 2010-01-07
US20190263852A1 (en) 2019-08-29
JP5607041B2 (ja) 2014-10-15
US20100003728A1 (en) 2010-01-07
US20160168193A1 (en) 2016-06-16
EP2318027A4 (en) 2016-12-28
CL2009001479A1 (es) 2010-01-04
EP2318027B1 (en) 2022-02-02
TW201006484A (en) 2010-02-16
PE20100258A1 (es) 2010-04-21

Similar Documents

Publication Publication Date Title
EP2318027A4 (en) ISOLATION OF CYCLOPAMINE
EP2376493A4 (en) DIHYDROPYRIMIDOPYRIMIDINDERIVAT
EP2380877A4 (en) PYRIDINE-3-CARBONSÄUREAMIDDERIVAT
DK2340021T3 (da) Substituerede pyrrolidin-2-carboxamider
BRPI0921327A2 (pt) Combinação de herbicida-protetor
BRPI0907376A2 (pt) Fotobiorretador
DK2308877T3 (da) Imidazopyridin-2-on-derivater
DK2080901T3 (da) Vindmølle-vindmålings-kompensation
EP2433940A4 (en) SPIROIMIDAZOLONDERIVAT
BRPI0915064A2 (pt) derivados de qunoxalinadiona
BRPI0914649A2 (pt) Piprazolo-quinazolinas
BRPI0814175A2 (pt) Micronização de polióis
EP2336132A4 (en) MORPHOLINPURINDERIVAT
BRPI0913832A2 (pt) derivados de pirrolopiridinilpirimidin-2-ilamina
EP2397480A4 (en) DIAZEPINEDIONEDERIVATE
DK2275414T3 (da) Cyclopentylacrylamidderivat
BR112012002336A2 (pt) compostos aza-heterocíclicos
BRPI0922652A2 (pt) Derivados de quinazolinamida
BRPI0907522A2 (pt) biarlamidas
BRPI0913234A2 (pt) derivados de tiazolilpiperidina
EP2401281A4 (en) PYRIMIDINPYRIMIDOINDAZOLDERIVAT
EP2280264A4 (en) STANDARD AGENTS
EP2492266A4 (en) 5-hydroxypyrimidine-4-carboxamide
ATE534634T1 (de) 2-phenyl-4-cyclopropyl-pyrimidinderivate
BRPI0909634A2 (pt) 2-aminoquinolinas

Legal Events

Date Code Title Description
B25A Requested transfer of rights approved

Owner name: INFINITY PHARMACEUTICALS, INC. (US)

B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 7A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2384 DE 13-09-2016 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.